| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
84,190,000 |
| Market
Cap: |
10.38(B) |
| Last
Volume: |
427,350 |
Avg
Vol: |
426,189 |
| 52
Week Range: |
$67.31 - $141.53 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 983 |
| Guru Rank Value : 0 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Sarepta Therapeutics is a commercial-stage biopharmaceutical company focused on helping patients through the discovery and development of RNA-targeted therapeutics, gene therapy and other genetic therapeutic modalities for the treatment of rare diseases. Co. is developing therapeutic candidates for a range of diseases and disorders, including Duchenne muscular dystrophy, Limb-girdle muscular dystrophies and other neuromuscular and central nervous system related disorders. Co.'s commercial product, EXONDYS 51® (eteplirsen) Injection is indicated for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
143,757 |
247,027 |
| Total Buy Value |
$0 |
$0 |
$13,295,068 |
$24,257,422 |
| Total People Bought |
0 |
0 |
3 |
3 |
| Total Buy Transactions |
0 |
0 |
5 |
7 |
| Total Shares Sold |
4,396 |
27,731 |
42,731 |
43,589 |
| Total Sell Value |
$602,450 |
$3,499,041 |
$5,099,841 |
$5,194,152 |
| Total People Sold |
2 |
7 |
7 |
7 |
| Total Sell Transactions |
2 |
7 |
8 |
9 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hudson Leslie |
Former CEOFormer CEO |
• – – |
2010-07-07 |
4 |
S |
$1.45 |
$292,019 |
D/D |
(200,000) |
384,559 |
|
- |
|
| Hudson Leslie |
Former CEOFormer CEO |
• – – |
2010-07-07 |
4 |
OE |
$0.92 |
$184,000 |
D/D |
200,000 |
584,559 |
|
- |
|
| Hudson Leslie |
Former CEOFormer CEO |
• – – |
2010-07-06 |
4 |
S |
$1.49 |
$32,462 |
D/D |
(21,089) |
384,559 |
|
- |
|
| Hudson Leslie |
Former CEOFormer CEO |
• – – |
2010-07-06 |
4 |
OE |
$0.92 |
$19,402 |
D/D |
21,089 |
405,648 |
|
- |
|
| Hudson Leslie |
Former CEOFormer CEO |
• – – |
2010-07-02 |
4 |
S |
$1.55 |
$201,416 |
D/D |
(128,911) |
384,559 |
|
- |
|
| Hudson Leslie |
Former CEOFormer CEO |
• – – |
2010-07-02 |
4 |
OE |
$0.92 |
$118,598 |
D/D |
128,911 |
513,470 |
|
- |
|
| Hudson Leslie |
Former CEOFormer CEO |
• – – |
2010-06-24 |
4 |
S |
$1.24 |
$63,659 |
D/D |
(51,338) |
384,559 |
|
- |
|
| Price Ben Gil |
Director |
– • – |
2010-06-11 |
4 |
B |
$1.44 |
$10,080 |
D/D |
7,000 |
98,982 |
2.39 |
- |
|
| Chase Anthony R |
Director |
– • – |
2010-06-09 |
4 |
B |
$1.40 |
$65,889 |
D/D |
46,500 |
391,467 |
2.39 |
- |
|
| Price Ben Gil |
Director |
– • – |
2010-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
91,982 |
|
- |
|
| Hodgman John |
Director |
– • – |
2010-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
10,000 |
|
- |
|
| Behrens M Kathleen |
Director |
– • – |
2010-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
|
- |
|
| Goolsbee William Alden |
Director |
– • – |
2010-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
15,000 |
|
- |
|
| Chase Anthony R |
Director |
– • – |
2010-05-21 |
4 |
B |
$1.33 |
$66,500 |
D/D |
50,000 |
344,967 |
2.39 |
- |
|
| Chase Anthony R |
Director |
– • – |
2010-05-18 |
4 |
B |
$1.41 |
$15,923 |
D/D |
11,068 |
294,967 |
2.39 |
- |
|
| Chase Anthony R |
Director |
– • – |
2010-05-17 |
4 |
B |
$1.41 |
$26,140 |
D/D |
18,539 |
283,899 |
2.39 |
- |
|
| Price Ben Gil |
Director |
– • – |
2010-05-13 |
4 |
B |
$1.36 |
$54,400 |
D/D |
40,000 |
126,982 |
2.39 |
- |
|
| Chase Anthony R |
Director |
– • – |
2010-04-22 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
169,360 |
|
- |
|
| Chase Anthony R |
Director |
– • – |
2010-04-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
169,312 |
|
- |
|
| Hudson Leslie |
Former CEOFormer CEO |
• – – |
2010-03-24 |
4 |
S |
$1.49 |
$31,926 |
D/D |
(21,427) |
435,897 |
|
- |
|
| Meldrum Asset Management, Llc |
|
– – – |
2010-03-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,935,696 |
|
- |
|
| Haywood Cheryl |
|
– – – |
2010-03-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
8,329,126 |
|
- |
|
| Eastbourne Capital Management Llc/ca |
10% Owner |
– – • |
2010-03-04 |
4 |
S |
$1.24 |
$5,077,361 |
D/D |
(4,094,646) |
5,659,211 |
|
- |
|
| Eastbourne Capital Management Llc/ca |
10% Owner |
– – • |
2009-11-11 |
4 |
S |
$1.41 |
$473,092 |
D/D |
(333,950) |
13,890,188 |
|
- |
|
| Eastbourne Capital Management Llc/ca |
10% Owner |
– – • |
2009-05-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
14,224,138 |
|
- |
|
524 Records found
|
|
Page 18 of 21 |
|
|
5.88 (5.01%) 
